Nexium (Esomeprazole)

Esomeprazole belongs to the proton pump inhibitor class. It binds irreversibly to the H+/K+ ATPase enzyme (the gastric proton pump) on parietal cells, blocking the final step of acid secretion. This action raises gastric pH, decreasing acidity and allowing damaged tissue to recover.

The specific dose of Nexium is determined by the prescribing healthcare professional based on the patient’s condition, severity, and response to therapy. Dosage may vary for different indications and should follow the prescriber’s instructions and local regulatory guidelines.

Safety data for esomeprazole in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant. Healthcare providers will assess individual circumstances before prescribing during pregnancy or while breastfeeding.

To request Nexium, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will verify trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Nexium (esomeprazole) is a proton pump inhibitor, offering more potent and longer‑lasting acid suppression than H2‑receptor antagonists such as ranitidine. Compared with other PPIs, esomeprazole provides consistent pharmacokinetic exposure, which may translate into reliable symptom control for many patients.

Nexium tablets should be stored at ambient temperature, below 25 °C, in the original packaging to protect from moisture. Keep the product out of direct sunlight and away from heat sources to maintain its stability and efficacy.

Nexium is taken orally, usually as a whole tablet swallowed with water. It is generally recommended to take the dose before a meal, often in the morning, but patients should follow the specific instructions provided by their prescriber.

Serious risks, though uncommon, include severe allergic reactions (anaphylaxis), Clostridioides difficile infection, low magnesium levels leading to muscle cramps or cardiac arrhythmias, and an increased risk of bone fractures with long‑term use. Patients should report any concerning symptoms to their healthcare provider promptly.

Nexium is contraindicated in individuals with known hypersensitivity to esomeprazole or any component of the formulation. Caution is advised for patients with severe liver disease, those taking certain interacting medications, and patients at high risk for osteoporosis or fractures when used long‑term.